NGEN
NervGen Pharma Corp. - Common stock (NGEN)
$78
About NervGen Pharma Corp. - Common stock (NGEN)
NervGen Pharma Corp. operates as a clinical stage biotech company. It engages in the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury and other neurotraumatic and neurologic conditions. The company was founded by Harold Punnett and William Joseph Radvak on January 19, 2017 and is headquartered in Vancouver, Canada.
Details
Daily high
$1.90
Daily low
$1.74
Price at open
$1.78
52 Week High
$6.30
52 Week Low
$1.58
Market cap
189.2M
Dividend yield
-
Volume
409,596
Avg. volume
538,712
P/E ratio
-3.28
NervGen Pharma Corp. - Common stock News
Details
Daily high
$1.90
Daily low
$1.74
Price at open
$1.78
52 Week High
$6.30
52 Week Low
$1.58
Market cap
189.2M
Dividend yield
-
Volume
409,596
Avg. volume
538,712
P/E ratio
-3.28